Literature DB >> 8903182

Helicobacter hepaticus, a recently recognized bacterial pathogen, associated with chronic hepatitis and hepatocellular neoplasia in laboratory mice.

J M Rice1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8903182      PMCID： PMC2626889          DOI： 10.3201/eid0104.950404

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN： 1080-6040            Impact factor:   6.883


× No keyword cloud information.
  12 in total

1.  Hepatotoxic activity of Campylobacter jejuni.

Authors:  E Kita; D Oku; A Hamuro; F Nishikawa; M Emoto; Y Yagyu; N Katsui; S Kashiba
Journal:  J Med Microbiol       Date:  1990-11       Impact factor: 2.472

2.  Helicobacter pylori isolated from the domestic cat: public health implications.

Authors:  L K Handt; J G Fox; F E Dewhirst; G J Fraser; B J Paster; L L Yan; H Rozmiarek; R Rufo; I H Stalis
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

3.  Diagnostic assay for Helicobacter hepaticus based on nucleotide sequence of its 16S rRNA gene.

Authors:  J K Battles; J C Williamson; K M Pike; P L Gorelick; J M Ward; M A Gonda
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

4.  Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori.

Authors:  A C Wotherspoon; C Doglioni; T C Diss; L Pan; A Moschini; M de Boni; P G Isaacson
Journal:  Lancet       Date:  1993-09-04       Impact factor: 79.321

5.  Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice.

Authors:  J G Fox; F E Dewhirst; J G Tully; B J Paster; L Yan; N S Taylor; M J Collins; P L Gorelick; J M Ward
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

6.  Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species.

Authors:  J M Ward; J G Fox; M R Anver; D C Haines; C V George; M J Collins; P L Gorelick; K Nagashima; M A Gonda; R V Gilden
Journal:  J Natl Cancer Inst       Date:  1994-08-17       Impact factor: 13.506

7.  Evaluation of antibiotic therapies for eradication of Helicobacter hepaticus.

Authors:  C J Foltz; J G Fox; L Yan; B Shames
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

8.  Chronic active hepatitis in mice caused by Helicobacter hepaticus.

Authors:  J M Ward; M R Anver; D C Haines; R E Benveniste
Journal:  Am J Pathol       Date:  1994-10       Impact factor: 4.307

9.  In-vitro hepatotoxic factor in Helicobacter hepaticus, H. pylori and other Helicobacter species.

Authors:  N S Taylor; J G Fox; L Yan
Journal:  J Med Microbiol       Date:  1995-01       Impact factor: 2.472

Review 10.  Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis.

Authors:  H Ohshima; H Bartsch
Journal:  Mutat Res       Date:  1994-03-01       Impact factor: 2.433
View more
  9 in total

1.  Increased oxidative DNA damage and hepatocyte overexpression of specific cytochrome P450 isoforms in hepatitis of mice infected with Helicobacter hepaticus.

Authors:  M A Sipowicz; P Chomarat; B A Diwan; M A Anver; Y C Awasthi; J M Ward; J M Rice; K S Kasprzak; C P Wild; L M Anderson
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

Review 2.  Association between Helicobacter spp. infections and hepatobiliary malignancies: a review.

Authors:  Fany Karina Segura-López; Alfredo Güitrón-Cantú; Javier Torres
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

3.  Inhibitory effect of Lactobacillus acidophilus on Helicobacter hepaticus in vitro.

Authors:  Manhua Zhang; Haiyang Zhang; Yan Li; Wenqian Qi; Xu Wang; Jiangbin Wang
Journal:  World J Microbiol Biotechnol       Date:  2013-01-05       Impact factor: 3.312

4.  Pathogenicity of Helicobacter ganmani in mice susceptible and resistant to infection with H. hepaticus.

Authors:  Cynthia G Alvarado; Andrew G Kocsis; Marcia L Hart; Marcus J Crim; Matthew H Myles; Craig L Franklin
Journal:  Comp Med       Date:  2015-02       Impact factor: 0.982

5.  Serum antibodies to Helicobacter hepaticus and Helicobacter pylori in patients with chronic liver disease.

Authors:  I Nilsson; S Lindgren; S Eriksson; T Wadström
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

6.  Cloning and expression of an immunogenic membrane-associated protein of Helicobacter hepaticus for use in an enzyme-linked immunosorbent assay.

Authors:  R S Livingston; L K Riley; R R Hook; C L Besch-Williford; C L Franklin
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

7.  Characterization of a Helicobacter hepaticus putA mutant strain in host colonization and oxidative stress.

Authors:  Navasona Krishnan; Alan R Doster; Gerald E Duhamel; Donald F Becker
Journal:  Infect Immun       Date:  2008-05-05       Impact factor: 3.441

8.  Chronic active hepatitis induced by Helicobacter hepaticus in the A/JCr mouse is associated with a Th1 cell-mediated immune response.

Authors:  M T Whary; T J Morgan; C A Dangler; K J Gaudes; N S Taylor; J G Fox
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

9.  Marked liver tumorigenesis by Helicobacter hepaticus requires perinatal exposure.

Authors:  Bhalchandra A Diwan; Marek Sipowicz; Daniel Logsdon; Peter Gorelick; Miriam R Anver; Kazimierz S Kasprzak; Lucy M Anderson
Journal:  Environ Health Perspect       Date:  2008-06-13       Impact factor: 9.031
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.